前往化源商城

61-52-9 靶点实验数据

HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL1781476
Protocol: N/A
Comment: Journal: Bioorg. Med. Chem.
Year: 2011
Volume: 19
Issue: 10
First Page: 3120
Last Page: 3127
DOI: 10.1016/j.bmc.2011.04.004
Standard TypeStandard RelationStandard ValueActivity Comment
Ratio CC50/IC50Not Determined
Ratio CC50/IC50=3557
Ratio CC50/IC50Not Determined
Ratio CC50/IC50Not Determined
Ratio CC50/IC50>5.7
Ratio CC50/IC50>8.2
Ratio CC50/IC50=0.95
Ratio CC50/IC50>25
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL1781475
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Bioorg. Med. Chem.
Year: 2011
Volume: 19
Issue: 10
First Page: 3120
Last Page: 3127
DOI: 10.1016/j.bmc.2011.04.004
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard Units
100CC50>100000nM
33.3CC50>33300nM
25CC50>25000nM
100CC50>100000nM
100CC50>100000nM
100CC50>100000nM
25CC50>25000nM
15CC50=15000nM
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:Luciferase [Photinus pyralis]
External ID: adst-fluc-km-fda-o1_regid
Protocol: Three microliters/well of substrate- buffer solution (0.01 mM D-Luciferin, 0.01 mM ATP, 50 mM Tris Acetate, 10 mM Mg Acetate, 0.01% Tween-20 and 0.038% BSA final concentrations) were dispensed into white solid-bottom 1536 well plates. Compounds were transferred to the plates in 23nl, and one microliter/well luciferase enzyme-buffer solution (10 nM P. pyralis luciferase and 50 mM Tris Acetate final concentrations) was dispensed yielding a final reaction volume of 4 ul/well. Luciferase luminescence was measured by a ViewLux plate reader within 5 minutes of enzyme-buffer addition. The % activity was determined by normalizing to the average readings of PTC124 (a positive control) relative to DMSO (0% Activity). The concentration-effect curves were then classified based on curve quality (r2), response magnitude and degree of measured activity.
Comment: Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
PhenotypePotencyEfficacyAnalysis CommentActivity_ScoreCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.0001640000 uMActivity at 0.0007600859 uMActivity at 0.00164 uMActivity at 0.00357 uMActivity at 0.00764 uMActivity at 0.016 uMActivity at 0.019 uMActivity at 0.041 uMActivity at 0.084 uMActivity at 0.098 uMActivity at 0.204 uMActivity at 0.443 uMActivity at 0.601 uMActivity at 1.020 uMActivity at 2.221 uMActivity at 3.851 uMActivity at 5.200 uMActivity at 11.13 uMActivity at 24.87 uMActivity at 50.60 uMActivity at 58.59 uMActivity at 123.2 uMActivity at 215.3 uMActivity at 288.0 uMCompound QC
Inactive0-4.49220.30.51734-4.606440 0 0 0 0 0 0 01.8042-4.672-4.1025-1.8343-3.7369-2.9082-0.0276-3.27281.8042QC'd by "SIGMA"
Inactive0-4.69224.0450.3458-8.5893-0.540 0 0 0 0 0 0 1-0.1897-6.0169-0.1640.01583.9661-1.6519-0.5167-6.3245-0.1897QC'd by "SigmaAldrich"
Inactive0-5.39224.95490.3662-3.09772.540 0 0 0 0 0 0 15.4199-1.74537.36030.4620.5234.8263-1.6338-2.99815.4199QC'd by "SigmaAldrich"
Inhibitor25.5748105.300940Partial curve; partial efficacy-4.59221.17050.9883-104.96170.3392-2.20 0 0 0 0 0 0 0-79.5165-3.79981.64450.16960.25152.0913-17.2656-49.2902-79.5165QC'd by "SigmaAldrich"
Inactive0-8.74224.44950.68780-6.086140 0 0 0 0 0 0 00.6926-3.82171.16341.2592-1.31090.3214-1.0557-0.36480.6926QC'd by "Chembridge"
Inactive0-4.89224.95490.392-0.6774-5.29640 0 0 0 0 0 0 0-0.8427-4.0002-6.8367-9.83-2.0415-1.9351-6.6372-0.5645-0.8427QC'd by "SigmaAldrich"
Inactive04-1.0545-8.31926.6299-1.3001-1.36740.8591-0.8748-5.7235-1.0545QC'd by "SigmaAldrich"
Inactive0-7.04220.80.711-0.5-4.896140 0 0 0 0 0 0 00.0168-4.0026-5.3301-2.4655-2.99060.3651-2.4180.11760.0168QC'd by "SigmaAldrich"
Inactive0-7.19221.41630.8466-0.5-6.118640 0 0 0 0 0 0 00.8131-6.3489-5.3075-4.1734-1.75011.2452-2.0927-0.96380.8131QC'd by "SigmaAldrich"
Inactive0-4.49224.0950.7889-0.6645-5.329340 0 0 0 0 0 0 0-0.9704-3.9692-5.7573-4.8944-5.7829-4.2413-6.1078-3.7926-0.9704QC'd by "SigmaAldrich"
Inactive0-4.99221.64360.9036-14.27221.540 1 0 0 0 0 0 1-0.79072.64976.5965-1.43033.18260.1904-2.1374-11.4768-0.7907QC'd by "Bosche"
Inactive0-8.69224.95490.89310.5-8.982640 0 0 0 0 0 0 01.1921-6.65221.36940.67421.17880.55330.1933-1.41651.1921QC'd by "SIGMA"
Inactive0-4.54221.64360.921-23.30751.540 0 0 0 0 0 0 0-17.3396-0.19295.88891.776-1.48911.55170.2982-9.8359-17.3396QC'd by "Bosche"
Inactive0-8.29222.47290.43281.5-4.903740 0 0 0 0 0 0 01.6497-4.50310.00170.95285.2306-1.05853.9254-2.26971.6497QC'd by "BIOMOL"
Inactive0-5.24222.40640.7478-1.9233240 0 0 0 0 0 0 0-0.73890.23281.80332.31213.13752.13380.241-2.8528-0.7389QC'd by "SigmaAldrich"
Inactive0-7.79224.95490.6788-3.3068140 0 0 0 0 0 0 14.31810.77691.4337-4.839-0.5865-4.7983-2.6758-3.15854.3181QC'd by "SigmaAldrich"
Inactive041.67591.4738-1.4676-2.88370.649-1.8659-1.6878-2.32581.6759QC'd by "Tocris"
Inactive04-0.47470.1407-1.50182.6348-4.58113.188-1.30740.2134-0.4747QC'd by "SigmaAldrich"
Inactive0-8.04224.95490.45590.3114440 0 0 0 0 0 0 00.54724.15642.6823-3.07390.68322.78941.3999-0.89020.5472QC'd by "SigmaAldrich"
Inactive0-4.39224.95490.91614-3.37340 0 0 0 0 0 0 013.8005-4.4775-3.8406-1.7248-1.4762-1.9012-4.2409-4.071613.8005QC'd by "SigmaAldrich"
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Hepatitis B virus
External ID: CHEMBL1781474
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Bioorg. Med. Chem.
Year: 2011
Volume: 19
Issue: 10
First Page: 3120
Last Page: 3127
DOI: 10.1016/j.bmc.2011.04.004

Target ChEMBL ID: CHEMBL613497
ChEMBL Target Name: Hepatitis B virus
ChEMBL Target Type: ORGANISM - Target is a complete organism
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
9.4IC50=9400nM
3.9IC50=3900nM
5.3IC50=5300nM
100IC50>100000nM
7.5IC50=7500nM
100IC50>100000nM
1IC50<1000nM
25IC50>25000nM